InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Xenon Pharmaceuticals Inc.

XENE Clue Score32
British Columbia, Canada Fiscal year ends December CIK 0001582313 Results filed 6 Aug 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

14
Insider
Date
Role
Action
Shares
Price
Amount
Christopher John Kenney
28 Aug 2026
Chief Medical Officer
Sold on a plan
700
$60.98
$42.68K
Christopher John Kenney
28 Aug 2026
Chief Medical Officer
Sold on a plan
6,368
$60.17
$383.15K
Gillian Cannon
5 Jun 2026
Director
Sold on a plan
1,190
$53.14
$63.24K
Gary Patou
5 Jun 2026
Director
Sold on a plan
1,322
$53.14
$70.25K
Ian Mortimer
13 Mar 2026
President & CEO
Sold on a plan
7,308
$55.23
$403.58K
Andrea DiFabio
13 Mar 2026
Chief Legal Officer
Sold on a plan
1,342
$55.23
$74.11K
Christopher John Kenney
13 Mar 2026
Chief Medical Officer
Sold on a plan
1,410
$55.23
$77.87K
Ian Mortimer
10 Mar 2026
President & CEO
Sold on a plan
11,269
$60.11
$677.36K
Andrea DiFabio
10 Mar 2026
Chief Legal Officer
Sold on a plan
2,607
$60.11
$156.70K
Christopher John Kenney
10 Mar 2026
Chief Medical Officer
Sold on a plan
2,771
$60.11
$166.56K
Ian Mortimer
8 Dec 2025
President & CEO
Sold on a plan
2,010
$46.32
$93.10K
Ian Mortimer
8 Dec 2025
President & CEO
Sold on a plan
8,820
$45.59
$402.10K
Ian Mortimer
5 Dec 2025
President & CEO
Sold on a plan
14,375
$45.03
$647.31K
Ian Mortimer
28 Nov 2025
President & CEO
Sold on a plan
97
$45.01
$4.37K
Show all 219 transactions →

What was left out

Form 4 filings counted 258
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 14
Sales straight out of an exercise 64
Sales at will 33
Transactions with no price 0
Shares from compensation/vesting 4,426,192
Sales filed before the plan box existed 23
History held since 6 Nov 2014